2026 NPPES data Hematology & Oncology Physician NPI 1528090248 MD
Verify on CMS →

STEPHEN GRAZIANO, MD

Hematology & Oncology Physician in SYRACUSE, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
462
Medicare Part D claims · 113 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.6325/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$129.6
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEPHEN GRAZIANO, MD reported a CMS MIPS final score of 81.6325/100 — below the 83.1 national average — and filed 462 Medicare Part D claims in 2023.

81.6325/100
MIPS score · -1 vs avg
462
Part D claims, 2023
79%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEPHEN GRAZIANO, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

STEPHEN GRAZIANO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about STEPHEN GRAZIANO, MD?

Near national average

NPI registry status

Active

Issued 07/06/2006

NPI 1528090248

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

462 45% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

81.6325/100 1.4675000000000011% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Medicare quality performance — MIPS

STEPHEN GRAZIANO, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
81.6325/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 81.6325/100 vs national avg 83.1

0%100%National avg83%81.6%
MIPS final score (Hematology & Oncology Physician) — 81.6325/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN GRAZIANO, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 750 E ADAMS ST, SYRACUSE, NY, 13210, with a listed phone of (315) 464-8200. NPI 1528090248 was issued on 07/06/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GRAZIANO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 462 prescription claims written by this provider, covering 113 Medicare beneficiaries and totaling roughly $469K in drug spend, split 21% brand-name and 79% generic by claim count, with an opioid prescribing rate of 12.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.6325/100 for the 2023 performance year (Quality 73.8681, Cost 52.7956), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

750 E ADAMS ST
SYRACUSE, NY 13210

Provider Details

NPI 1528090248
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/06/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.6325
Final Score
Avg: 83.1
73.8681
Quality
52.7956
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where STEPHEN GRAZIANO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AUBURN COMMUNITY HOSPITAL
AUBURN, NY
DEPARTMENT OF MEDICINE MEDICAL SERV GRP AT SUNY HLTH SCI CTR SYR IN
VERONA, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN GRAZIANO, MD. Source: openpaymentsdata.cms.gov.

Total received

$130

Largest payer

Merck Sharp & Dohme LLC

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to STEPHEN GRAZIANO, MD. To verify STEPHEN GRAZIANO, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

STEPHEN GRAZIANO, MD — brand share 21.0%
Specialty average (est.)

21% brand-name claims vs 79% generic, on 462 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

462
Total Claims
$469K
Total Drug Cost
113
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
505
Total Day Supply
11,090
Brand vs Generic
21% brand / 79% generic
Brand Drug Cost
$421K
Generic Drug Cost
$48K
Opioid Claims
59 (12.8% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
2.76
Gender Split
52% female / 48% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEPHEN GRAZIANO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ondansetron Hcl
44
Prochlorperazine Maleate
39
Oxycodone Hcl
32
Prednisone
20
Xarelto
Rivaroxaban
20
Gabapentin
18
Levothyroxine Sodium
18
Fludrocortisone Acetate
14
Potassium Chloride
14
Letrozole
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How STEPHEN GRAZIANO, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

STEPHEN GRAZIANO, MD's 462 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GRAZIANO.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN GRAZIANO, MD's specialty?
STEPHEN GRAZIANO, MD specializes in Hematology & Oncology Physician and practices in SYRACUSE, New York. Credentials: MD.
How much does STEPHEN GRAZIANO, MD prescribe under Medicare Part D?
In 2023, STEPHEN GRAZIANO, MD wrote 462 Medicare Part D claims totaling $469K in drug costs for 113 beneficiaries.
What is STEPHEN GRAZIANO, MD's Medicare quality score?
STEPHEN GRAZIANO, MD has a CMS MIPS Final Score of 81.6325/100 (Quality: 73.8681, Cost: 52.7956). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEPHEN GRAZIANO, MD located?
STEPHEN GRAZIANO, MD is located at 750 E ADAMS ST, SYRACUSE, NY, 13210. Phone: (315) 464-8200.
What is STEPHEN GRAZIANO, MD's NPI number?
STEPHEN GRAZIANO, MD's National Provider Identifier (NPI) is 1528090248, issued on 07/06/2006.
Does STEPHEN GRAZIANO, MD prescribe more brand-name or generic drugs?
STEPHEN GRAZIANO, MD's prescribing is 21% brand-name and 79% generic drugs by claim count, with $421K in brand drug costs.
Does STEPHEN GRAZIANO, MD prescribe opioids?
Yes, STEPHEN GRAZIANO, MD had 59 opioid claims in 2023 with an opioid prescribing rate of 12.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does STEPHEN GRAZIANO, MD prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN GRAZIANO, MD's most frequently prescribed drugs include Ondansetron Hcl, Prochlorperazine Maleate, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN GRAZIANO, MD accept Medicare?
STEPHEN GRAZIANO, MD appears in CMS Medicare data with 462 Part D claims and 113 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN GRAZIANO, MD's credentials?
STEPHEN GRAZIANO, MD's NPI is 1528090248 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology